Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
37
0.330
Why?
DNA
1
2010
581
0.280
Why?
Intensive Care Units, Neonatal
2
2018
117
0.280
Why?
Asthma
1
2010
293
0.280
Why?
Infant, Premature
4
2019
335
0.230
Why?
Medicaid
2
2018
267
0.210
Why?
Disabled Children
2
2013
72
0.200
Why?
Infant, Newborn
7
2019
2907
0.180
Why?
Hospitalization
2
2017
705
0.180
Why?
Persistent Fetal Circulation Syndrome
1
2019
10
0.170
Why?
Health Care Costs
2
2018
171
0.170
Why?
Chronic Disease
3
2011
612
0.170
Why?
Infant, Low Birth Weight
1
2018
75
0.160
Why?
Child, Preschool
7
2018
4146
0.160
Why?
Continuity of Patient Care
1
2018
64
0.150
Why?
Immunologic Deficiency Syndromes
1
2016
20
0.140
Why?
Clinical Protocols
1
2017
122
0.140
Why?
Hypoglycemia
1
2016
61
0.140
Why?
Infant, Premature, Diseases
1
2017
91
0.140
Why?
DNA Copy Number Variations
2
2016
114
0.140
Why?
Developmental Disabilities
1
2016
126
0.130
Why?
Child
8
2018
7337
0.130
Why?
Hospitals, Pediatric
3
2013
272
0.120
Why?
Comprehensive Health Care
1
2013
9
0.120
Why?
Emergency Service, Hospital
1
2018
538
0.120
Why?
Infant
6
2018
3817
0.110
Why?
Blood Cells
1
2012
58
0.100
Why?
Child, Exceptional
1
2011
6
0.100
Why?
Genome, Human
1
2012
131
0.100
Why?
Cost Savings
1
2011
67
0.100
Why?
Parents
1
2013
344
0.090
Why?
Fetal Blood
1
2010
67
0.090
Why?
Follow-Up Studies
2
2018
2387
0.090
Why?
Gene Expression Regulation, Developmental
1
2010
151
0.090
Why?
Genetic Association Studies
1
2010
136
0.090
Why?
Longitudinal Studies
3
2018
746
0.090
Why?
Ambulatory Care
1
2011
229
0.090
Why?
Patient Care Team
1
2011
273
0.080
Why?
Outpatient Clinics, Hospital
1
2009
44
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
541
0.080
Why?
Genotype
1
2010
599
0.080
Why?
Time Factors
2
2018
3212
0.080
Why?
Humans
13
2022
54246
0.080
Why?
Child Health Services
1
2009
98
0.080
Why?
Home Care Services
1
2009
79
0.080
Why?
Female
8
2018
28418
0.070
Why?
Polymorphism, Single Nucleotide
1
2010
552
0.070
Why?
Male
7
2018
27312
0.070
Why?
DNA Methylation
1
2010
574
0.070
Why?
Cohort Studies
3
2018
1543
0.070
Why?
Patient Discharge
2
2018
353
0.060
Why?
Prospective Studies
1
2010
2604
0.060
Why?
Embryonic Stem Cells
1
2022
17
0.060
Why?
Cell Differentiation
2
2022
720
0.050
Why?
Age Factors
2
2018
1195
0.050
Why?
Peptide Hydrolases
1
2002
67
0.050
Why?
Acetylcysteine
1
2002
118
0.050
Why?
Phosphoproteins
1
2002
116
0.050
Why?
Adolescent
3
2018
6885
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
131
0.050
Why?
Adipocytes
1
2002
129
0.050
Why?
Arkansas
3
2013
2094
0.050
Why?
Cell Survival
1
2022
657
0.050
Why?
Time
1
2018
36
0.040
Why?
Indomethacin
1
2018
40
0.040
Why?
Ibuprofen
1
2018
28
0.040
Why?
Neurons
1
2022
486
0.040
Why?
Proteins
1
2002
376
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
44
0.040
Why?
Birth Weight
1
2019
126
0.040
Why?
United States
3
2018
5200
0.040
Why?
Infant, Newborn, Diseases
1
2016
64
0.030
Why?
Patient Readmission
1
2018
242
0.030
Why?
Incidence
1
2018
1082
0.030
Why?
Logistic Models
1
2018
990
0.030
Why?
Databases, Factual
1
2018
684
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
206
0.030
Why?
Length of Stay
1
2018
683
0.030
Why?
Young Adult
2
2016
4308
0.030
Why?
Genomics
1
2016
310
0.030
Why?
Blood Glucose
1
2016
488
0.030
Why?
Risk Assessment
1
2018
1361
0.030
Why?
Health Care Surveys
1
2013
194
0.030
Why?
Twins, Monozygotic
1
2012
17
0.030
Why?
Individuality
1
2012
31
0.030
Why?
Patient-Centered Care
1
2013
133
0.030
Why?
Myelodysplastic Syndromes
1
2012
79
0.030
Why?
Cerebral Palsy
1
2010
43
0.020
Why?
Aged
2
2016
10041
0.020
Why?
Cost-Benefit Analysis
1
2011
291
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
69
0.020
Why?
Multivariate Analysis
1
2011
643
0.020
Why?
Middle Aged
2
2016
13070
0.020
Why?
Adult
2
2016
14182
0.020
Why?
Program Evaluation
1
2009
374
0.020
Why?
Quality of Life
1
2013
922
0.020
Why?
Rural Population
1
2011
599
0.020
Why?
Retrospective Studies
1
2018
6432
0.020
Why?
Mutation
1
2012
1501
0.020
Why?
Aged, 80 and over
1
2012
3429
0.010
Why?
Leupeptins
1
2002
8
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
5
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
28
0.010
Why?
Treatment Outcome
1
2013
5604
0.010
Why?
Calpain
1
2002
28
0.010
Why?
Kinetics
1
2002
692
0.010
Why?
Nuclear Proteins
1
2002
252
0.010
Why?
Cell Line
1
2002
1153
0.010
Why?
Animals
1
2002
14385
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description